Detalhe da pesquisa
1.
Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry.
Ann Rheum Dis
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38594056
2.
Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis.
Eur J Clin Invest
; 54(2): e14095, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715584
3.
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care.
J Rheumatol
; 51(4): 378-389, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38224992
4.
Associated factors to non-medical and medical use of psychoactive medication among Mexican adolescents and adults in a national household survey.
J Am Pharm Assoc (2003)
; : 102056, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38401839
5.
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries.
Ann Rheum Dis
; 82(2): 175-181, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36100351
6.
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis.
Rheumatology (Oxford)
; 61(12): 4741-4751, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323903
7.
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response.
Rheumatology (Oxford)
; 61(9): 3799-3807, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34940840
8.
Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables.
Rheumatol Int
; 42(6): 1085-1096, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34755205
9.
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration.
Ann Rheum Dis
; 80(11): 1410-1418, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083206
10.
Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries?
Rheumatology (Oxford)
; 59(9): 2556-2562, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31998955
11.
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA.
Rheumatology (Oxford)
; 59(7): 1640-1650, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665497
12.
Clinically significant renal involvement in primary Sjögren's syndrome is associated with important morbidity: data from the Spanish Sjögrenser cohort.
Clin Exp Rheumatol
; 38 Suppl 126(4): 116-124, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33095138
13.
Prevalence of fibromyalgia and associated factors in Spain.
Clin Exp Rheumatol
; 38 Suppl 123(1): 47-52, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31928589
14.
Digestive involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registry.
Clin Exp Rheumatol
; 38 Suppl 126(4): 110-115, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33025900
15.
Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome.
Rheumatol Int
; 40(8): 1259-1265, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32533289
16.
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration.
Ann Rheum Dis
; 78(11): 1536-1544, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31431486
17.
ESSDAI activity index of the SJÖGRENSER cohort: analysis and comparison with other European cohorts.
Rheumatol Int
; 39(6): 991-999, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30891620
18.
Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry.
Rheumatol Int
; 39(3): 509-515, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30353269
19.
Factors associated with severe dry eye in primary Sjögren's syndrome diagnosed patients.
Rheumatol Int
; 38(6): 1075-1082, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29556704
20.
Fibromyalgia prevalence and associated factors in primary Sjögren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER).
Clin Exp Rheumatol
; 35 Suppl 105(3): 28-34, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28240585